Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousUnreasonable Patent Applicant Delay and the USPTO Backlog
By Dennis Crouch
Over 1.2 million non-provisional patent applications are pending examination at the USPTO. Of those, more than 700,000 have not received even a preliminary examination. The backlog is the source of a tremendous amount of bad publicity for the USPTO. At a recent PPAC meeting, former USPTO Deputy Director Stephen Pinkos asked an important question regarding the backlog. Namely, Mr. Pinkos asked USPTO officials to identify the portion of the backlog that can be attributed to patent applicant delays rather than to the USPTO.
The Study: To answer Mr. Pinkos question, I looked at the Patent Term Adjustment (PTA) History for 1,248 randomly selected patents issued April-July 2010. Ordinarily, a patent's enforceable term is 20–years from its application filing-date. However, an adjustment is provided when the USPTO delays in issuing a patent. However, the PTA is reduced by patent applicant delays that go beyond the ordinary two and three month deadlines for responding to USPTO requests. To be clear, the applicant-delay offset does not account for all applicant delay, but rather only delays that show a failure 'to engage in reasonable efforts to conclude prosecution.' Thus, for this study, I term the calculated applicant delay offset as the 'unreasonable applicant delay.'
Results: The 1,248 patents in my sample had an average application pendency of 46.3 months. The average unreasonable applicant delay was only 2.0 months per patent (+/– 0.2 months). This applicant delay represents 4.3% of the pendency time for all of the patents. As the cumulative frequency chart (below) shows, a large percentage of the patents (43%) had no unreasonable applicant delay and the median unreasonable applicant delay was only 11 days. Many of the longest delays were associated with revival of abandoned applications and late submission of information disclosure statements.

Notes:
Full post as published by Patently Obvious on July 09, 2010 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
Indianapolis
alleging the city's police are overly aggressive against the homeless in violation of the protection of free speech and unreasonable searches guaranteed in the US Constitution.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Sony
to Pay $18.5 Million For Patent Infringment

USPTO Implements Patent Application Backlog Reduction Stimulus Plan
USPTO: small entity patent applicants have opportunity to move up in the queue
USPTO expands patent application backlog reduction stimulus plan to all applicants
USPTO and UKIPO Announce Plan to Reduce Global Application Backlog
Announcement: USPTO Seeks to Rehire Limited Number of Former Examiners








